Actionable news
0
All posts from Actionable news
Actionable news in OPK: OPKO HEALTH Inc,

OPKO Health, Inc.

OPKO Health, Inc. has a fundamental score of 34 and has a relative valuation of UNDERVALUED. OPKO Health, Inc. lies at the bottom left quadrant of CapitalCube's Value - Price Matrix. We call this space a Value Trap. At this level, OPKO Health, Inc. is potentially undervalued, since it trades lower than its CapitalCube Implied price of 11.63. However, its fundamental analysis score is also on the lower side at 34, begging the question whether the low price is on account of the weaker fundamentals.SpreadsheetOPKO Health, Inc.'s price of USD 6.54 is lower than CapitalCube's implied price of USD 11.63. CapitalCube believes that at these levels, OPKO Health, Inc. is undervalued and has upside potential. Over the last 52 week period, the stock has fluctuated between USD 5.85 and USD 12.15.Spreadsheet

  • From a peer analysis angle, relative underperformance over the last year has improved more recently.
  • It trades at a lower Price/Book multiple (1.74) than its peer median (4.56).
  • OPK-US's EBITDA-based price implies better than peer median growth.The market seems to expect a turnaround in the company's current EBITDA-based return on equity.
  • OPK-US has relatively low profit margins and median asset efficiency.
  • The company's year-on-year change in revenues and earnings are better than the median among its peer group.
  • OPK-US's return on assets has improved from below median to about median among its peers over the last five years.
  • The company's relatively low gross and pre-tax margins suggest a non-differentiated product portfolio and not much control on operating costs relative to peers.
  • Compared with the peers chosen, OPK-US has had faster revenue growth in prior years and a current Price/EBITDA ratio that suggests faster growth in the future suggesting superior growth expectations.
  • The company seems to be over-investing in a business with median returns.
  • OPK-US's operating performance may not allow it to raise additional debt.

The information presented in this report has been obtained from sources deemed to be reliable, but AnalytixInsight does not make any representation about the accuracy, completeness, or timeliness of this information. This report was produced by AnalytixInsight for informational purposes only and nothing contained herein should be construed as an offer to buy or sell or as a solicitation of an offer to buy or sell any security or derivative instrument. This report is current only as of the date that it was published and the opinions, estimates, ratings and other information may change without notice or publication. Past performance is no guarantee of future results. Prior to making an investment or other financial decision, please consult with your financial, legal and tax advisors. AnalytixInsight shall not be liable for any party's use of this report. AnalytixInsight is not a broker-dealer and does not buy, sell, maintain a position, or make a market in any security referred to herein. One of the principal tenets for us at AnalytixInsight is that the best person to handle your finances is you. By your use of our services or by reading any of our reports, you're agreeing that you bear responsibility for your own investment research and investment decisions. You also agree that AnalytixInsight, its directors, its employees, and its agents will not be liable for any investment decision made or action taken by you and others based on news, information, opinion, or any other material generated by us and/or published through our services. For a complete copy of our disclaimer, please visit our website www.analytixinsight.com.


More